GL1X · GenesisL1 explorer

Research workbench

Co-crystal structure of MNK2 in complex with inhibitor

Analyse Co-crystal structure of MNK2 in complex with inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6CKI
Type
protein
Length
271 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
MAP kinase-interacting SERINE/THREONINE-protein kinase 2
EC
2.7.11.1
UniProt
Q9HBH9
Ligands
FZJ, ZN
Pockets
2 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMAP kinase-interacting SERINE/THREONINE-protein kinase 2 (EC 2.7.11.1)protein27142% helix, 15% strandQ9HBH9

Ligands and binding sites

  • FZJ · 3,3-dimethyl-6-[(pyrimidin-4-yl)amino]-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione · ligand · chains A
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13370.660.8143FZJ
2760.310.7313empty

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 6CKI · Co-crystal structure of MNK2 in Complex With Inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9HBH9 · AlphaFold monomer V2.0 prediction for MAP kinase-interacting SERINE/THREONINE-protein… · a predicted model of the same protein · chain A against A, TM-score 0.88

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.